HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer
Clinical trial NCT07621484 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07621484
- Sponsor
- Shanghai Changzheng Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-05-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.